BiomX Inc.'s latest marketcap:
As of 11/19/2025, BiomX Inc.'s market capitalization has reached $10.21 M. According to our data, BiomX Inc. is the 41446th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 10.21 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -18,567,000 |
| Shares Out | 26.18 M |
| EPS (ttm) | -2.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 11/12/2025 |
BiomX Inc.'s yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 11/19/2025 | $10.21 M | -24.74% | 41446 |
| 12/31/2024 | $13.27 M | 3.09% | n/a |
| 12/29/2023 | $12.87 M | 130.01% | n/a |
| 12/30/2022 | $5.6 M | -87.59% | n/a |
| 12/31/2021 | $45.11 M | -69.57% | n/a |
| 12/31/2020 | $148.28 M | -32.95% | n/a |
| 12/31/2019 | $221.16 M | n/a |
Company Profile
BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.
The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis.
It also developing BX004, a phage therapy for cystic fibrosis and non-cystic fibrosis bronchiectasis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials.
The company was founded in 2015 and is headquartered in Ness Ziona, Israel.
Frequently Asked Questions
-
What is BiomX Inc.'s (PHGE) current market cap?As of 11/19/2025, BiomX Inc. (including the parent company, if applicable) has an estimated market capitalization of $10.21 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does BiomX Inc. (PHGE) rank globally by market cap?BiomX Inc. global market capitalization ranking is approximately 41446 as of 11/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.